Physician profile
Beth Sullivan Walsh
NPI 1205820503
$1,357.29
in general payments reported to CMS, 2019-2025
17 companies · $369 in 2025
The $369 reported for 2025 was more than what 89% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $72.36 · 2021: $87.17 · 2022: $120 · 2023: $177 · 2024: $275 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $281.58 | 2019-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Tris Pharma INC | $281.26 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $129.69 | 2024-2025 | Azstarys |
| Sanofi Pasteur INC. | $120.70 | 2021-2025 | |
| Pfizer INC. | $99.90 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $96.73 | 2019-2024 | |
| Seqirus USA INC | $92.86 | 2024-2025 | Flucelvax |
| Supernus Pharmaceuticals, INC. | $47.98 | 2025 | Qelbree |
| Neos Therapeutics, LP | $43.45 | 2019 | |
| Welch Allyn | $41.04 | 2021 | |
| Shire North American Group INC | $27.53 | 2019 | |
| Kaleo, INC. | $20.55 | 2023 | Auvi-Q |
| Verrica Pharmaceuticals INC. | $19.76 | 2024 | Ycanth |
| Cranial Technologies, INC | $15.02 | 2019 | |
| Phadia US INC. | $14.38 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adlon Therapeutics L.P. | $13.18 | 2019 | |
| Glaxosmithkline, LLC. | $11.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.